HEMOPHILIA TREATMENT: NEW INSIGHTS CONTRIBUTE TO MINIMIZE OR ELIMINATE SIDE EFFECTS IN THE FUTURE
Immune responses against Factor VIII, which is used to treat hemophilia A (bleeding disorder), are influenced by the microenvironment of antigen presenting cells. This is the result of a scientific study conducted in cooperation between the Institute Krems Bioanalytics of IMC University of Applied Sciences Krems ...
Source: pharmiweb.com